| Technology Hardware, Storage & Peripherals Industry | Information Technology Sector | Eric K. Olson CEO | LSE Exchange | US8293927039 ISIN |
| US Country | 20 Employees | 29 Jul 2019 Last Dividend | 20 Dec 2022 Last Split | 13 Feb 2014 IPO Date |
Sintx Technologies, Inc. is a pioneering advanced materials company focused on the research, development, and commercialization of medical devices made from silicon nitride. The company actively works on applications spanning biomedical, industrial, and antipathogenic fields within the United States. Originally known as Amedica Corporation, Sintx Technologies has rebranded itself while maintaining its commitment to innovation in materials science. Founded in 1996, the company's headquarters are strategically located in Salt Lake City, Utah, a hub for biomedical research and development.
These are core products that utilize silicon nitride's unique properties, such as its resistance to bacteria and its ability to promote bone growth. These characteristics make it suitable for various medical implants and devices.
This product is crucial for manufacturers seeking the mechanical and chemical properties of silicon nitride in a versatile powder form. It's widely used in industrial applications and the development of antipathogenic surfaces.
These coatings leverage silicon nitride's biocompatibility and resistance to wear and corrosion, making them ideal for enhancing the longevity and performance of medical devices and industrial components.
Composite materials blend silicon nitride with other substances to achieve specific performance objectives, such as improved strength or durability, for both industrial and medical applications.
This offering indicates Sintx's diversification into high-performance thermoplastics, known for their chemical resistance and mechanical properties, suitable for demanding environments in various industrial applications.